Sunday, February 16, 2025
HomeIntelligenceFace to FaceNot until a made-in-China mRNA vaccine: Alidad Tash

Not until a made-in-China mRNA vaccine: Alidad Tash

Alidad Tash estimates Macau’s 2023 GGR to reach about 40 percent of 2019 levels and that we won’t be getting out of a covid zero policy well into the second quarter of next year – once a Made-in-China mRNA has been approved, and administered to the vast majority of the Mainland’s population.

In a special edition of AGB’s Face-to-Face sessions the managing director of 2NT8 goes over some of the questions on the industry’s minds: Genting, Covid-zero, digital currency, next year’s GGR outlook.

AGBrief Editorial
AGBrief Editorialhttps://agbrief.com/about-asia-gaming-brief/
The AGBrief Editorial Team is a group of contributors living around the world that are connected to Asia Gaming Brief. They are active members in pursuing the sources of our news, making them reliable and accurate for our readers.

MORE ARTICLES

FOLLOW US

daily newsletter